semaglutide mash therapy enters a more competitive era Semaglutide rebalances one-carbon metabolism (OCM)

Strong preoperative planning, including stopping select prescription medications and herbal supplements, goes a long way to decrease this risk

Given that finerenone was beneficial in patients already receiving an SGLT2 inhibitor, our findings point to finerenone as a new second pillar in HFmrEF/HFpEF. Approved in 2021 based on data from the FIDELIO-DKD and FIGARO-DKD trials, Bayer announced on August 05, 2024 the FINEARTS-HF trial had met its primary endpoint

Many people report getting GLP-1s through online telemedicine companies, where a doctor is required to evaluate and prescribe the drug, but barriers to entry can be too low

Another common recommendation people with PCOS can expect to hear: That they should lose weight

GLP-1 prescriptions grew from ~9M in Q4 2022 (source) to ~24M by Q4 2024 (source)